Association of Metformin With the Development of Age-related Macular Degeneration in the Diabetes Prevention Program Outcomes Study-Reply

JAMA Ophthalmol. 2023 Jul 1;141(7):697. doi: 10.1001/jamaophthalmol.2023.1892.

Authors

Amitha Domalpally¹, Qing Pan², Emily Y Chew³

Affiliations

¹ Wisconsin Reading Center, Department of Ophthalmology, University of Wisconsin School of Medicine and Public and Health, Madison.
² Department of Statistics, George Washington University, Washington, DC.
³ Division of Epidemiology and Clinical Applications, Clinical Trials Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland.

PMID: 37227711
DOI: 10.1001/jamaophthalmol.2023.1892

No abstract available

Publication types

Letter
Comment

MeSH terms

Diabetes Mellitus, Type 2* / complications
Diabetes Mellitus, Type 2* / prevention & control
Humans
Hypoglycemic Agents / therapeutic use
Macular Degeneration* / prevention & control
Metformin* / therapeutic use

Substances

Metformin
Hypoglycemic Agents